Menu
Back to Journals » Journal of Hepatocellular Carcinoma » Volume 11
Original Research
Efficacy and Safety of Transarterial Chemoembolization Plus Donafenib with or without Immune Checkpoint Inhibitors as the First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Propensity Score Matching Analysis
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 1,295 | Dovepress* | 1,243+ | 33 | 1,276 | |
| PubMed Central* | 52 | 50 | 102 | ||
| Totals | 1,295 | 83 | 1,378 | ||
| *Since 9 January 2024 | |||||
View citations on PubMed Central and Google Scholar